Cargando…
Human monoclonal antibodies to group B streptococcus. Reactivity and in vivo protection against multiple serotypes
Group B streptococcal (GBS) infections cause significant mortality and morbidity among infants. Passive antibody immunotherapy has been proposed as treatment for infected infants. To this end, two human mAb- secreting cell lines were produced by EBV immortalization of human B cells. The mAbs were sp...
| Formato: | Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
The Rockefeller University Press
1988
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189032/ https://www.ncbi.nlm.nih.gov/pubmed/3049909 |